1. Home
  2. ADMA vs RUN Comparison

ADMA vs RUN Comparison

Compare ADMA & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • RUN
  • Stock Information
  • Founded
  • ADMA 2004
  • RUN 2007
  • Country
  • ADMA United States
  • RUN United States
  • Employees
  • ADMA N/A
  • RUN N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • RUN Industrial Machinery/Components
  • Sector
  • ADMA Health Care
  • RUN Miscellaneous
  • Exchange
  • ADMA Nasdaq
  • RUN Nasdaq
  • Market Cap
  • ADMA 3.7B
  • RUN 3.7B
  • IPO Year
  • ADMA N/A
  • RUN 2015
  • Fundamental
  • Price
  • ADMA $15.05
  • RUN $19.47
  • Analyst Decision
  • ADMA Strong Buy
  • RUN Buy
  • Analyst Count
  • ADMA 3
  • RUN 20
  • Target Price
  • ADMA $27.67
  • RUN $20.18
  • AVG Volume (30 Days)
  • ADMA 3.1M
  • RUN 9.8M
  • Earning Date
  • ADMA 11-06-2025
  • RUN 11-06-2025
  • Dividend Yield
  • ADMA N/A
  • RUN N/A
  • EPS Growth
  • ADMA 469.09
  • RUN N/A
  • EPS
  • ADMA 0.85
  • RUN N/A
  • Revenue
  • ADMA $474,174,000.00
  • RUN $2,129,272,000.00
  • Revenue This Year
  • ADMA $21.17
  • RUN $11.64
  • Revenue Next Year
  • ADMA $26.03
  • RUN $8.79
  • P/E Ratio
  • ADMA $17.41
  • RUN N/A
  • Revenue Growth
  • ADMA 43.58
  • RUN 3.27
  • 52 Week Low
  • ADMA $13.50
  • RUN $5.38
  • 52 Week High
  • ADMA $25.67
  • RUN $22.44
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 47.74
  • RUN 51.53
  • Support Level
  • ADMA $14.35
  • RUN $19.18
  • Resistance Level
  • ADMA $15.60
  • RUN $21.80
  • Average True Range (ATR)
  • ADMA 0.52
  • RUN 1.28
  • MACD
  • ADMA 0.13
  • RUN -0.17
  • Stochastic Oscillator
  • ADMA 65.17
  • RUN 20.97

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

Share on Social Networks: